STATE-OF-THE-ART PAPER
Hormone Replacement Therapy and the Cardiovascular System
Lessons Learned and Unanswered Questions
Pamela Ouyang, MB, BS, FACC*,a,*,
Erin D. Michos, MD* and
Richard H. Karas, MD, PhD, FACC ,b
* Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Molecular Cardiology Research Center and the Division of Cardiology, Tufts-New England Medical Center, Boston, Massachusetts
Manuscript received October 5, 2005;
accepted October 21, 2005.
* Reprint requests and correspondence: Dr. Pamela Ouyang, Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue, A1 East, Baltimore, Maryland 21224 (Email: pouyang{at}jhmi.edu).
Cardiovascular disease is the leading cause of death among women in the U.S., exceeding breast cancer mortality in women of all ages. Women present with cardiovascular disease a decade after men, and this has been attributed to the protective effect of female ovarian sex hormones that is lost after menopause. Animal and observational studies have shown beneficial effects of hormone therapy when it is initiated early in the perimenopausal period or before the development of significant atherosclerosis. However, randomized, placebo-controlled trials in older women have not shown any benefit in either primary prevention or secondary prevention of cardiovascular events, with a concerning trend toward harm. This review outlines the lessons learned from the basic science, animal, observational, and randomized trials, and then summarizes yet-unanswered questions of hormone therapy and cardiovascular risk.
|
Abbreviations and Acronyms
| | CHD = coronary heart disease | | CI = confidence interval | | CRP = C-reactive protein | | HDLC = high-density lipoprotein cholesterol | | HT = hormone therapy | | IMT = intima-medial thickness | | LDLC = low-density lipoprotein cholesterol | | MI = myocardial infarction | | MPA = medroxyprogesterone acetate |
|
This article has been cited by other articles:
|
|
|
|
 
D. Xing, S. Nozell, Y.-F. Chen, F. Hage, and S. Oparil
Estrogen and Mechanisms of Vascular Protection
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2009;
29(3):
289 - 295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Shufelt and C. N. Bairey Merz
Contraceptive hormone use and cardiovascular disease.
J. Am. Coll. Cardiol.,
January 20, 2009;
53(3):
221 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Matyal
Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management: A Core Review
Anesth. Analg.,
July 1, 2008;
107(1):
37 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Vitale, G. Mercuro, E. Cerquetani, G. Marazzi, R. Patrizi, F. Pelliccia, M. Volterrani, M. Fini, P. Collins, and G. M.C. Rosano
Time Since Menopause Influences the Acute and Chronic Effect of Estrogens on Endothelial Function
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2008;
28(2):
348 - 352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Weikert, J. Dierkes, K. Hoffmann, K. Berger, D. Drogan, K. Klipstein-Grobusch, J. Spranger, M. Mohlig, C. Luley, and H. Boeing
B Vitamin Plasma Levels and the Risk of Ischemic Stroke and Transient Ischemic Attack in a German Cohort
Stroke,
November 1, 2007;
38(11):
2912 - 2918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. P. Liu and M. Fukuoka
Sex Hormones as Novel Risk Biomarkers for Atherosclerosis in Peripheral Vascular Disease
J. Am. Coll. Cardiol.,
September 11, 2007;
50(11):
1077 - 1079.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Collins, G. Rosano, C. Casey, C. Daly, M. Gambacciani, P. Hadji, R. Kaaja, T. Mikkola, S. Palacios, R. Preston, et al.
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
Eur. Heart J.,
August 2, 2007;
28(16):
2028 - 2040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Barton, M. R. Meyer, and E. Haas
Hormone Replacement Therapy and Atherosclerosis in Postmenopausal Women: Does Aging Limit Therapeutic Benefits?
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2007;
27(8):
1669 - 1672.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yuan and J. Xu
Loss-of-Function Deletion of the Steroid Receptor Coactivator-1 Gene in Mice Reduces Estrogen Effect on the Vascular Injury Response
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2007;
27(7):
1521 - 1527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Sunday, C. Osuna, D. N. Krause, and S. P. Duckles
Age alters cerebrovascular inflammation and effects of estrogen
Am J Physiol Heart Circ Physiol,
May 1, 2007;
292(5):
H2333 - H2340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
